| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0078-0825-81 | 0078-0825 | HUMAN PRESCRIPTION DRUG | Sandostatin LAR Depot | octreotide acetate | KIT | 20160722 | N/A | NDA | NDA021008 | Novartis Pharmaceuticals Corporation | 1 KIT in 1 KIT (0078-0825-81) * 6 mL in 1 VIAL (0078-0804-61) * 2 mL in 1 SYRINGE | |||
| 0078-0818-81 | 0078-0818 | HUMAN PRESCRIPTION DRUG | Sandostatin LAR Depot | octreotide acetate | KIT | 20160722 | N/A | NDA | NDA021008 | Novartis Pharmaceuticals Corporation | 1 KIT in 1 KIT (0078-0818-81) * 6 mL in 1 VIAL (0078-0797-61) * 2 mL in 1 SYRINGE | |||
| 0078-0811-81 | 0078-0811 | HUMAN PRESCRIPTION DRUG | Sandostatin LAR Depot | octreotide acetate | KIT | 20160722 | N/A | NDA | NDA021008 | Novartis Pharmaceuticals Corporation | 1 KIT in 1 KIT (0078-0811-81) * 6 mL in 1 VIAL (0078-0790-61) * 2 mL in 1 SYRINGE |